Complications of chronic kidney disease

American Journal of Nursing

Volumn 105, Issue 6, 2005, Pages 40-50

  Legg, Veronica ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Ren Care Group of the Midwest Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CALCIMIMETIC AGENT; VITAMIN D;

ANAMNESIS; BONE TURNOVER; CHRONIC KIDNEY DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; DIETARY INTAKE; HUMAN; HYPERPARATHYROIDISM; INFLAMMATION; LABORATORY TEST; NUTRITIONAL DISORDER; OSTEODYSTROPHY; REVIEW; KIDNEY DISEASE; NURSING; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RENAL OSTEODYSTROPHY;

HUMANS; INFLAMMATION; KIDNEY DISEASES; NUTRITION DISORDERS; QUALITY OF LIFE; RENAL OSTEODYSTROPHY;

EID: 20444497310     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000446-200506000-00024     Document Type: Review

References (39)

1. De Boer IH, et al. The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol 2002;13(11):2762-9.
2. Slatopolsky E, Delmez JA. Pathogenesis of secondary hyperparathyroidism. Nephrol Dial Transplant 1996;11 Suppl 3:130-5.
3. Fukagawa M, et al. Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases. Am J Kidney Dis 2001;38(4 Suppl 1):S152-5.
4. Reilly RF. CKD series: disturbances of mineral metabolism in chronic kidney disease. Hospital Physician 2003;39(4):23-31.
5. Mucsi I, Hercz G. Relative hypoparathyroidism and adynamic bone disease. Am J Med Sci 1999;317(6):405-9.
6. Ganesh SK, et al. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001;12(10):2131-8.
7. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(4 Suppl 3):S1-201.
8. Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 2000;36(6):1115-21.
9. Olmastroni M, et al. Magnetic resonance imaging of renal osteodystrophy in children. Pediatr Radiol 1997;27(11):865-8.
10. Lobao R, et al. High prevalence of low bone mineral density in pre-dialysis chronic kidney disease patients: bone histomorphometric analysis. Clin Nephrol 2004;62(6):432-9.
11. Fukagawa M. The role of parathyroidectomy: surgical issues. Program and abstracts from American Society of Nephrology Renal Week 2003; Nov 12-17; San Diego, CA.
12. Finn WF, et al. Efficacy and safety of lanthanum carbonate for reduction of serum phosphorus in patients with chronic renal failure receiving hemodialysis. Clin Nephrol 2004;62 (3):193-201.
13. Tomasello S, et al. Phosphate binders, K/DOQI guidelines, and compliance: the unfortunate reality. Dial Transplant 2004;33(5):236-40.
14. Schroeder K, et al. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev 2004(2): CD004804.
15. Haynes RB, et al. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002(2):CD000011.
16. Ikizler TA, et al. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 1995;6(5):1386-91.
17. Stenvinkel P, et al. A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. Nephrol Dial Transplant 2002;17(7):1266-74.
18. Hakim RM, Levin N. Malnutrition in hemodialysis patients. Am J Kidney Dis 1993;21(2):125-37.
19. Barrett BJ, et al. Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis 1997;29 (2):214-22.
20. Kalantar-Zadeh K, et al. Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis 1998;31(2):263-72.
21. Levey AS, et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis 1996;27(5): 652-63.
22. National Institutes of Health. Optimal calcium intake. NIH Consens Statement 1994;12(4):1-31.
23. Pupim LB, et al. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest 2002;110(4):483-92.
24. Caglar K, et al. Therapeutic effects of oral nutritional supplementation during hemodialysis. Kidney Int 2002;62(3): 1054-9.
25. Kalantar-Zadeh K, et al. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003;42(5):864-81.
26. Go AS, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351(13):1296-305.
27. Knight EL, et al. Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol 2004;15(7):1897-903.
28. Kalantar-Zadeh K, et al. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004;80(2):299-307.
29. Ifudu O, et al. Low hematocrit may connote a malnutrition/inflammation syndrome in hemodialysis patients. Dial Transplant 2002;31(12):845-7, 78.
30. Himmelfarb J, et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62(5):1524-38.
31. Pecoits-Filho R, et al. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter. Nephrol Dial Transplant 2002;17 Suppl 11:28-31.
32. Vernaglione L, et al. Does atorvastatin influence serum C-reactive protein levels in patients on long-term hemodialysis? Am J Kidney Dis 2004;43(3):471-8.
33. Kristal B, et al. Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in hemodialysis patients. Nephron 1999;81(4):406-13.
34. De Caterina R, Manes C. Inflammation in early atherogenesis: impact of ACE inhibition. Eur Heart J Suppl 2003;5 (Suppl A):A15-A24.
35. Ghiadoni L, et al. Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol 2004;17(4):512-9.
36. Boaz M, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000;356 (9237):1213-8.
37. Castaneda C, et al. Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. Am J Kidney Dis 2004;43(4):607-16.
38. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
39. Mapes DL, et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003;64(1): 339-49.